183 related articles for article (PubMed ID: 12183272)
1. Efficacies of quinupristin-dalfopristin combined with vancomycin in vitro and in experimental endocarditis due to methicillin-resistant Staphylococcus aureus in relation to cross-resistance to macrolides, lincosamides, and streptogramin B- type antibiotics.
Pavie J; Lefort A; Zarrouk V; Chau F; Garry L; Leclercq R; Fantin B
Antimicrob Agents Chemother; 2002 Sep; 46(9):3061-4. PubMed ID: 12183272
[TBL] [Abstract][Full Text] [Related]
2. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
Zarrouk V; Bozdogan B; Leclercq R; Garry L; Feger C; Carbon C; Fantin B
Antimicrob Agents Chemother; 2001 Apr; 45(4):1244-8. PubMed ID: 11257041
[TBL] [Abstract][Full Text] [Related]
3. Quinupristin-dalfopristin combined with beta-lactams for treatment of experimental endocarditis due to Staphylococcus aureus constitutively resistant to macrolide-lincosamide-streptogramin B antibiotics.
Vouillamoz J; Entenza JM; Féger C; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 2000 Jul; 44(7):1789-95. PubMed ID: 10858332
[TBL] [Abstract][Full Text] [Related]
4. Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis.
Fantin B; Leclercq R; Garry L; Carbon C
Antimicrob Agents Chemother; 1997 May; 41(5):931-5. PubMed ID: 9145847
[TBL] [Abstract][Full Text] [Related]
5. In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus.
Kang SL; Rybak MJ
J Antimicrob Chemother; 1997 May; 39 Suppl A():33-9. PubMed ID: 9511060
[TBL] [Abstract][Full Text] [Related]
6. Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus.
Fantin B; Leclercq R; Merlé Y; Saint-Julien L; Veyrat C; Duval J; Carbon C
Antimicrob Agents Chemother; 1995 Feb; 39(2):400-5. PubMed ID: 7726505
[TBL] [Abstract][Full Text] [Related]
7. Antistaphylococcal activities of quinupristin/dalfopristin in vitro across platelet-fibrin matrices and in experimental endocarditis.
Berthaud N; Huet Y; Diallo N; Desnottes JF
J Antimicrob Chemother; 1997 May; 39 Suppl A():93-8. PubMed ID: 9511071
[TBL] [Abstract][Full Text] [Related]
8. Influence of resistance to streptogramin A type antibiotics on the activity of quinupristin-dalfopristin in vitro and in experimental endocarditis due to Staphylococcus aureus.
Zarrouk V; Bozdogan B; Leclercq R; Garry L; Carbon C; Fantin B
Antimicrob Agents Chemother; 2000 May; 44(5):1168-73. PubMed ID: 10770747
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of macrolide, lincosamide, and streptogramin resistance among staphylococci in a tertiary care hospital in Athens, Greece.
Vallianou N; Evangelopoulos A; Hadjisoteriou M; Avlami A; Petrikkos G
J Chemother; 2015; 27(6):319-23. PubMed ID: 25112954
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of quinupristin/dalfopristin versus vancomycin, alone or in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a rabbit arthritis model.
Hamel A; Caillon J; Jacqueline C; Batard E; Potel G
Int J Antimicrob Agents; 2008 Feb; 31(2):158-60. PubMed ID: 18006281
[TBL] [Abstract][Full Text] [Related]
11. Bactericidal activity of quinupristin-dalfopristin against Staphylococcus aureus: clindamycin susceptibility as a surrogate indicator.
Fuchs PC; Barry AL; Brown SD
Antimicrob Agents Chemother; 2000 Oct; 44(10):2880-2. PubMed ID: 10991879
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme. Sentry Participants Group.
Schmitz FJ; Verhoef J; Fluit AC
J Antimicrob Chemother; 1999 Jun; 43(6):783-92. PubMed ID: 10404317
[TBL] [Abstract][Full Text] [Related]
13. Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500.
Entenza JM; Drugeon H; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 1995 Jul; 39(7):1419-24. PubMed ID: 7492078
[TBL] [Abstract][Full Text] [Related]
14. Combination of quinupristin-dalfopristin and gentamicin against methicillin-resistant Staphylococcus aureus: experimental rabbit endocarditis study.
Batard E; Jacqueline C; Boutoille D; Hamel A; Drugeon HB; Asseray N; Leclercq R; Caillon J; Potel G; Bugnon D
Antimicrob Agents Chemother; 2002 Jul; 46(7):2174-8. PubMed ID: 12069971
[TBL] [Abstract][Full Text] [Related]
15. Interactions of quinupristin-dalfopristin with eight other antibiotics as measured by time-kill studies with 10 strains of Staphylococcus aureus for which quinupristin-dalfopristin alone was not bactericidal.
Fuchs PC; Barry AL; Brown SD
Antimicrob Agents Chemother; 2001 Sep; 45(9):2662-5. PubMed ID: 11502549
[TBL] [Abstract][Full Text] [Related]
16. A review of in-vitro antibacterial activity of quinupristin/dalfopristin against methicillin-susceptible and -resistant Staphylococcus aureus.
Low DE; Nadler HL
J Antimicrob Chemother; 1997 May; 39 Suppl A():53-8. PubMed ID: 9511063
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of macrolide-lincosamide-streptogramin resistances among staphylococcal clinical isolates at a university medical center. Is false susceptibility to new macrolides and clindamycin a contemporary clinical and in vitro testing problem?
Sanchez ML; Flint KK; Jones RN
Diagn Microbiol Infect Dis; 1993; 16(3):205-13. PubMed ID: 8477574
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. III. Novel, inducible resistance to macrolide-lincosamide-streptogramin B (MLS) antibiotics.
Inouye Y; Morifuji K; Masumi N; Sugiyama M; Takesue Y; Kodama T; Yokoyama T
Hiroshima J Med Sci; 1993 Sep; 42(3):101-7. PubMed ID: 8253604
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of telithromycin and quinupristin/dalfopristin against methicillin-resistant coagulase-negative staphylococci with defined resistance genotypes.
Novotná G; Spízek J; Janata J
Folia Microbiol (Praha); 2007; 52(6):593-9. PubMed ID: 18450221
[TBL] [Abstract][Full Text] [Related]
20. Synercid plus vancomycin for the treatment of severe methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci infections: evaluation of 5 cases.
Sgarabotto D; Cusinato R; Narne E; Scano F; Zignol M; Gambino A; Cattelan A; Meneghetti F; Cadrobbi P
Scand J Infect Dis; 2002; 34(2):122-6. PubMed ID: 11928842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]